Literature DB >> 9619263

New opportunities for the development of cancer immunotherapies.

S A Rosenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9619263

Source DB:  PubMed          Journal:  Cancer J Sci Am        ISSN： 1081-4442


× No keyword cloud information.
  3 in total

1.  Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.

Authors:  Smita K Nair; Michael Morse; David Boczkowski; R Ian Cumming; Ljiljana Vasovic; Eli Gilboa; H Kim Lyerly
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

Review 2.  DNA vaccines to attack cancer.

Authors:  Freda K Stevenson; Christian H Ottensmeier; Peter Johnson; Delin Zhu; Sarah L Buchan; Katy J McCann; Joanne S Roddick; Andrew T King; Feargal McNicholl; Natalia Savelyeva; Jason Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

3.  Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Authors:  B Thurner; I Haendle; C Röder; D Dieckmann; P Keikavoussi; H Jonuleit; A Bender; C Maczek; D Schreiner; P von den Driesch; E B Bröcker; R M Steinman; A Enk; E Kämpgen; G Schuler
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.